Skyrizi (risankizumab-rzaa) is not a one-dose-fits-all medication. The dosing schedule depends entirely on the condition being treated. For plaque psoriasis, the dosing is every 12 weeks after two starter doses. For psoriatic arthritis and Crohn’s disease, the schedule is different and more frequent. This article breaks down the exact dosing for each approved condition so you know what to expect.
What Is Skyrizi and How Does It Work?
Skyrizi is a biologic medication. It targets a specific protein in the body called interleukin-23 (IL-23). This protein drives inflammation in several chronic conditions. By blocking IL-23, Skyrizi reduces the inflammatory response that causes symptoms.
The active ingredient is risankizumab. It is given as an injection under the skin. Most patients can self-inject after proper training from their healthcare provider. Skyrizi is not a pill and it is not taken daily.
Understanding the dosing schedule matters because missing doses can reduce effectiveness. Taking it too often does not improve results and may increase risk.
How Often Do You Take Skyrizi For Each Condition?
Skyrizi is approved by the U.S. Food and Drug Administration (FDA) for three main conditions. Each has its own specific dosing schedule. The schedule is based on clinical trial data, not on symptom severity or body weight.
Here is the standard dosing for each approved condition:
- Plaque psoriasis: 150 mg at week 0, week 4, then every 12 weeks thereafter.
- Psoriatic arthritis: 150 mg at week 0, week 4, then every 12 weeks thereafter.
- Crohn’s disease: 600 mg at week 0, week 4, and week 8, then every 8 weeks thereafter.
The psoriasis and psoriatic arthritis schedules are identical. The Crohn’s disease schedule uses a higher dose and a shorter interval between maintenance doses.
Skyrizi Dosing for Plaque Psoriasis
Plaque psoriasis is the most common form of psoriasis. It causes thick, scaly patches on the skin. Skyrizi was first approved for this condition in 2019.
The dosing schedule is straightforward. You receive your first injection at week 0. The second injection comes at week 4. After that, you inject once every 12 weeks. This is called maintenance dosing.
Clinical trials showed that most patients see significant skin clearance within the first few months. Some patients notice improvement after the first dose. Full results may take up to 16 weeks or longer.
The 12-week interval is longer than many other psoriasis biologics. This is a key advantage for patients who prefer fewer injections. Some other biologics require dosing every 4 to 8 weeks.
Skyrizi Dosing for Psoriatic Arthritis
Psoriatic arthritis affects the joints and can cause pain, swelling, and stiffness. It often occurs alongside psoriasis, but not always. Skyrizi was approved for this condition in 2022.
The dosing schedule is the same as for plaque psoriasis. You take 150 mg at week 0 and week 4. After that, maintenance dosing is every 12 weeks.
Patients with psoriatic arthritis may also have skin symptoms. The same dose treats both the joint symptoms and the skin plaques. You do not need a separate schedule for each symptom.
Clinical trials demonstrated improvements in joint pain, swelling, and physical function. Some research suggests that response may take longer for joint symptoms compared to skin symptoms. Patience is important during the first months of treatment.
Skyrizi Dosing for Crohn’s Disease
Crohn’s disease is a type of inflammatory bowel disease. It causes inflammation in the digestive tract. Skyrizi was approved for Crohn’s disease in 2022.
The dosing for Crohn’s disease is different from the skin and joint conditions. The induction phase uses a higher dose of 600 mg. This is given as three separate intravenous (IV) infusions at week 0, week 4, and week 8.
After induction, the maintenance phase begins. You receive 360 mg as an injection under the skin every 8 weeks. This is a higher dose and a shorter interval than the psoriasis schedule.
The IV induction doses are typically given at an infusion center or clinic. The maintenance injections can be self-administered at home after training.
This more intensive schedule reflects the nature of Crohn’s disease. It is a systemic inflammatory condition that often requires stronger initial treatment to bring inflammation under control.
What Happens If You Miss a Dose?
Missing a dose of Skyrizi is not ideal, but it happens. What you should do depends on which phase of treatment you are in.
If you miss a dose during the induction phase for psoriasis or psoriatic arthritis, contact your healthcare provider. They will advise you on when to take the next dose. Do not double up on your own.
If you are in the maintenance phase and miss a dose, take it as soon as you remember. Then resume your regular schedule from that date. This means your next dose will be 12 weeks from the day you actually took the missed dose, not the original planned date.
For Crohn’s disease, missed doses are more complicated because the induction phase involves IV infusions. Contact your gastroenterologist immediately if you miss an infusion. They will need to reschedule your treatment plan.
Consistency matters with biologics. Irregular dosing can reduce effectiveness and may increase the risk of developing antibodies against the medication.
How Long Does Skyrizi Take to Work?
Response time varies by condition and by person. For plaque psoriasis, some patients see improvement within 4 weeks. Most clinical improvement occurs within 16 weeks of starting treatment.
For psoriatic arthritis, joint symptoms may take longer to improve than skin symptoms. Some patients report meaningful relief within 8 to 12 weeks. Full response can take several months.
For Crohn’s disease, the induction phase is designed to bring symptoms under control quickly. Many patients notice improvement after the first or second infusion. Maintenance therapy keeps the disease in remission.
If you see no improvement after several months, talk to your doctor. Some patients do not respond to Skyrizi at all. Others may need a different biologic medication.
No clinical evidence currently confirms that taking Skyrizi more frequently than prescribed improves outcomes. Stick to the approved schedule unless your doctor specifically instructs otherwise.
Skyrizi Dosing Comparison Table
| Condition | Induction Dose | Induction Schedule | Maintenance Dose | Maintenance Interval |
|---|---|---|---|---|
| Plaque Psoriasis | 150 mg | Week 0 and Week 4 | 150 mg | Every 12 weeks |
| Psoriatic Arthritis | 150 mg | Week 0 and Week 4 | 150 mg | Every 12 weeks |
| Crohn’s Disease | 600 mg (IV) | Week 0, Week 4, Week 8 | 360 mg | Every 8 weeks |
This table summarizes the FDA-approved dosing for each condition. Your doctor may adjust your schedule based on your individual response, but this is the standard framework.
Can You Take Skyrizi With Other Medications?
Skyrizi is often used alongside other treatments. For psoriasis, it may be combined with topical creams or phototherapy. For psoriatic arthritis, some patients also take methotrexate or other DMARDs.
For Crohn’s disease, Skyrizi may be used with corticosteroids during the induction phase. Some patients continue other immunosuppressants as well.
Live vaccines should not be given while taking Skyrizi. The medication affects the immune system, and live vaccines could cause infection. Talk to your doctor about vaccination timing before starting treatment.
Tell your healthcare provider about every medication you take, including over-the-counter drugs and supplements. Some combinations may increase infection risk.
What Are the Common Side Effects?
Skyrizi is generally well tolerated, but side effects do occur. The most common ones include upper respiratory infections, headache, fatigue, and injection site reactions.
Injection site reactions include redness, pain, or swelling where the injection was given. These are usually mild and resolve within a few days.
Because Skyrizi suppresses part of the immune system, it may increase the risk of infections. Serious infections are uncommon but possible. Seek medical attention if you develop fever, persistent cough, or other signs of infection.
No large human trials have confirmed a link between Skyrizi and cancer. The FDA requires monitoring for malignancies in all biologic medications, but the overall risk appears low based on current data.
Frequently Asked Questions
How often do you take Skyrizi for psoriasis?
You take 150 mg at week 0 and week 4, then every 12 weeks after that. This is the standard maintenance schedule for plaque psoriasis.
Is Skyrizi taken every week?
No, Skyrizi is never taken weekly. The shortest interval between doses is every 8 weeks, which applies only to Crohn’s disease maintenance.
Can you take Skyrizi at home?
Yes, maintenance doses for psoriasis, psoriatic arthritis, and Crohn’s disease can be self-injected at home. The induction doses for Crohn’s disease are given intravenously at a clinic or infusion center.
How long do you stay on Skyrizi?
Skyrizi is a long-term treatment for chronic conditions. Most patients continue maintenance dosing indefinitely as long as the medication remains effective and side effects are manageable.
Knowing your Skyrizi schedule is essential for getting the full benefit of treatment. Mark your calendar, set reminders, and keep open communication with your healthcare team. If you have questions about your specific dosing plan, ask your doctor or pharmacist directly.
